REKOVELLE PEN for S.C. Injection General Drug Use Survey (Controlled Ovarian Stimulation in Assisted Reproductive Technologies)
NCT06545877 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2025-08-20
Summary
This survey targets controlled ovarian stimulation with this drug for the development of multiple oocytes in women undergoing assisted reproduction (ART) such as in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI).
Conditions
Sponsors & Collaborators
-
Ferring Pharmaceuticals
lead INDUSTRY
Principal Investigators
-
Global Clinical Compliance · Ferring Pharmaceuticals
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-09-16
- Primary Completion
- 2026-02-28
- Completion
- 2029-06-22
Countries
- Japan
Study Locations
More Related Trials
-
Using a Fixed Dosage of Follitropin Delta for Ovarian Stimulation for Intrauterine Insemination: Rekovelle for Intrauterine Successful Experience (RISE)
NCT07153367 ·Status: RECRUITING ·Phase: PHASE2
-
Higher Dose of Rekovelle in Oocyte Donors
NCT04778358 ·Status: COMPLETED ·Phase: PHASE2
-
Post-Marketing Surveillance (PMS) Protocol of REKOVELLE Pre-Filled Pen (Follitropin Delta)
NCT04654039 ·Status: COMPLETED
-
A Trial to Investigate the Efficacy and Safety of FE 999302 as add-on Treatment to Follitropin Delta (REKOVELLE) in Women Undergoing Controlled Ovarian Stimulation.
NCT03564509 ·Status: COMPLETED ·Phase: PHASE2
-
Investigation of a Long-Acting Follicle Stimulating Hormone in Infertile Women Undergoing Assisted Reproductive Technology (ART)
NCT00505752 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study of a Single Injection of SCH 900962 Versus Daily recFSH Injections in Women Undergoing Controlled Ovarian Stimulation (Study P06029)
NCT01144416 ·Status: COMPLETED ·Phase: PHASE3
-
Comparing Two Types of Needle for Oocytes Retrieval
NCT03611907 ·Status: COMPLETED ·Phase: NA
-
A Dose-response Trial Using FE 999049 in Japanese Women Undergoing in Vitro Fertilisation (IVF) / Intracytoplasmic Sperm Injection (ICSI) Treatment
NCT02309671 ·Status: COMPLETED ·Phase: PHASE2
-
Trial to Assess the Clinical Efficacy and Safety of MSJ-0011 in Inducing Ovulation in Anovulatory or Oligo-ovulatory Japanese Women
NCT01653743 ·Status: COMPLETED ·Phase: PHASE3
-
A Randomised, Phase II, Comparative Study With a Parallel Control for Evaluating the Efficacy and Safety of Combined Treatment of Lutropin Alpha and Recombinant Human Luteinizing Hormone in the Middle of the Controlled Ovarian Stimulation Follicular Phase in Women With Reduced Ovarian Reserve
NCT01110707 ·Status: COMPLETED ·Phase: PHASE2
-
Ovarian Stimulation With Recombinant Gonadotropins vs. Human Menopausal Gonadotropin in In Vitro Fertilization
NCT02322398 ·Status: COMPLETED
-
Single Dose Recombinant Human Follicle Stimulating Hormone Fc Husion Protein (KN015) in Healthy Volunteers
NCT03192527 ·Status: UNKNOWN ·Phase: PHASE1
-
Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Japanese Women
NCT03228680 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Anti-mullerian Hormone Levels as Predictive of IVF Outcomes in Women Over 38 Years Old
NCT01219387 ·Status: COMPLETED
-
The Relationship Between Serum AMH Dynamics and Early or Normal Ovarian Response to Corifollitropin Alfa
NCT04482751 ·Status: UNKNOWN
-
Levels of Anti-Mullerian Hormone (AMH) During Ovarian Stimulation With Gonadotropins
NCT02237781 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Recombinant Follicle-stimulating Hormone in Treatment for Infertility
NCT05266924 ·Status: UNKNOWN ·Phase: PHASE3
-
A Dose-response Trial Using rFSH FE 999049 in Women Undergoing IVF/ICSI Treatment
NCT01426386 ·Status: COMPLETED ·Phase: PHASE2
-
Anti-mullerian Hormone Levels in Healthy Females
NCT04537390 ·Status: RECRUITING ·Phase: NA
-
Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Pan-Asian Women
NCT03296527 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Compare Efficacy and Safety of Primapur and Gonal-f in Women for Assisted Reproductive Treatment
NCT03088137 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Study of Recombinant Human Follitropin for Injection Assisted in COH Assisted IVF-ET
NCT03071172 ·Status: UNKNOWN ·Phase: PHASE3
-
Clinical Research Study to Learn About the Effect and Safety of Different Doses of FE 999302 When Given as a Single Dose for Final Development of the Eggs After Ovarian Stimulation
NCT05571111 ·Status: WITHDRAWN ·Phase: PHASE2
-
Effect of GnRH Antagonist vs Agonist Long on IVF Outcome, Peak Estradiol Level,and Duration of Stimulation
NCT01669291 ·Status: COMPLETED ·Phase: NA
-
Gonadotropin Type in Ovarian Stimulation
NCT02437032 ·Status: COMPLETED ·Phase: PHASE4